IDXX IDEXX Laboratories, Inc.

NASDAQ
$698.47

IDEXX Laboratories, Inc. (IDXX) is expected to report earnings on February 1, 2027, before the market open. The consensus earnings estimate is $3.30 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +11.8% since its last earnings release on November 2, 2026.

IDEXX Laboratories Beat Expectations, Raises Guidance
Monday, November 2, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 1
Monday · 6:30 AM ET
Earnings Whisper
-
vs $3.30
Rev est $1.18B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $686.19

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About IDEXX Laboratories, Inc.

IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for the veterinary, bioresearch, water, livestock, poultry and dairy markets.

Sector

Healthcare

Industry

Diagnostic Substances

Charts powered in part by Lightweight Charts™ by TradingView.